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Abstract
Background: Periodontal disease is a highly prevalent illness that affects many dogs, reaching up to 85 %
prevalence in individuals over the age of 4 years. Currently the drug of choice for combating the formation of
dental plaque in these animals, the etiologic agent of the disease, is chlorhexidine, which has several side effects
reported. Thus, surveys are conducted throughout the world in order to identify potential substitutes for
antimicrobial therapy and prevention of periodontal disease. The objective of the work was to evaluate the
antimicrobial activity of β-caryophyllene against bacteria from dog’s dental plaque in vitro and in vivo. The
minimum inhibitory concentration was evaluated by agar microdilution assay, the induction or inhibition of
bacterial adherence by sub-inhibitory concentrations in 96-well plates, and reduction of dental plaque formation in
mongrel dogs subjected to topical solution with β-caryophyllene for 15 days.
Results: Results showed minimum inhibitory concentrations above 100 mg/mL for 25 % of the isolates, 100 mg/mL
for 3 %, 50 mg/mL for 25 %, 25 mg/mL for 12 %, 12.5 mg/mL for 19 % and 6.25 mg/mL for 16 %. Bacterial
adherences of three Enterococcus sp., one Streptococcus sp., one Haemophilus sp., one Aerococcus sp., one Bacillus
sp. and one Lactococcus sp. isolates were inhibited by subinhibitory concentration. One Lactococcus sp., one Bacillus
sp. and one Streptococcus sp. were stimulated to adhere by concentrations of 0.19, 1.56 and 0.78 mg/mL,
respectively. In vivo assay showed reduction in dental plaque formation by β-caryophyllene, with final plaque
coverage of 23.3 ± 2.6 % of the total area of the teeth, with significant difference compared with chlorhexidine
group (37.5 ± 3.7 % - p < 0.05) and negative control group (65.5 ± 2.5 % - p < 0.001).
Conclusions: The results showed that β-caryophyllene has antimicrobial activity against the proliferation of dog’s
dental plaque-forming bacteria representing a suitable alternative to the use of chlorhexidine in prophylaxis and
treatment of periodontal disease of dogs.
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Background
Periodontal disease is a highly prevalent illness that
affects many dogs, reaching up to 85 % prevalence in
individuals over the age of 4 years [1]. It affects the sup-
porting and protective structures of the teeth and its
aetiological agent is the bacterial plaque that develops
on the tooth surface, and the immune reaction to infec-
tion [2]. Tooth brushing is the most suitable procedure
for the prevention of periodontal disease through mech-
anical removal of dental plaque; however, some alterna-
tives can be employed simultaneously to brushing with
the intention of increasing the efficiency of plaque re-
moval. Among these alternatives is the administration of
antibacterial substances, which, by preventing the prolif-
eration or adhesion of bacteria to the teeth surface, in-
hibit the development of periodontal disease [3].
In addition, there is evidence that biofilm formation
can be stimulated by certain antimicrobials in sub-
inhibitory concentrations, which makes it necessary to
investigate a potential stimulus for bacterial adherence
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by antimicrobial agents, making its use in therapy im-
possible [4, 5]. Studies have indicated several classes of an-
tibiotics, including tetracyclines, quinopristina-dalfopristin,
erythromycin and enrofloxacin, which stimulate the
formation of biofilms by Staphylococcus epidermidis and
Escherichia coli [5, 6]. In contrast, the discovery of thera-
peutic agents that are capable of inhibiting biofilm forma-
tion, even in sub-inhibitory concentrations, would be useful
for the prevention of periodontal disease by inhibiting the
formation of dental plaque [3].
Chlorhexidine is currently the drug of choice for com-
bating dental plaque bacteria, and is usually commercia-
lised at the concentration of 0.12 % [7]. However, the use
of this drug has some side effects, such as darkening of
the tooth enamel, loss of taste, burning sensation in the
oral cavity and ulceration of the oral mucosa, as well as a
bitter taste and the fact that it enables the emergence of
resistant bacteria [8]. Therefore, there is a need to search
for alternatives to this drug for prophylaxis and treatment
of periodontal disease [9].
The β-caryophyllene is a sesquiterpene (C15H24 – Fig. 1),
identified in the CAS (Chemical Abstract Service) under
number 87-44-5; this is found in many plant sources, and
shows great potential [10]. Studies have shown low tox-
icity and high applicability, with this substance being used
for several purposes, including local anaesthesia [11], anti-
inflammatory action [12, 13], antispasmodic action [14],
antimicrobial activity [15], anxiolytic [16], and protection
against ischemic injury in neurons [17], among others.
Several studies to identify antimicrobial activity have been
conducted with plants that have high percentages of β-
caryophyllene in their composition, presenting positive
results for these extracts against several pathogens: Thymus
kotschyanus [18], Spiranthera odoratissima [19], Lantana
sp. [20],Vernonia remotiflorae V. brasiliana [21], Syzygium
cumini [22], and Lippia gracillis [23], among others.
Considering the high prevalence of periodontal disease
in dogs, the side effects caused by the drug of choice
currently to combat microorganisms of dental plaque, and
the described antimicrobial potential of β-caryophyllene,
the aim of this work was to evaluate the antimicrobial ac-
tivity of this phytochemical against dental plaque bacteria
on dogs both in vitro and in vivo, and evaluate its ability
to interfere in the adherence of bacterial plaque isolates.
Methods
Bacterial isolates
Thirty two bacterial isolates were used from ten different
genera, which were obtained from dental plaque of mon-
grel dogs aged between 1 and 2 years, fed with dry feed
ad libitum. The number of isolates within each genus
was selected following the same percentage that they
represented within the total isolates obtained from dogs
in the study performed by Pieri [24]: six Streptococcus
sp., six Staphylococcus sp., six Enterococcus sp., three
Lactobacillus sp., three Leuconostoc sp. two Actinomyces
sp., two Bacillus sp., two Lactococcus sp., one Aerococcus
sp., and one Haemophilus sp.
Minimum inhibitory concentration (MIC)
The in vitro assay was performed by adaptation of the agar
macrodilution technique [25], which was modified for
agar microdilution performed in 96-well microtitre plates.
The β-caryophyllene (≥98.5 %, Sigma-Aldrich, Saint Louis,
MO, USA) was incorporated within agar brain heart infu-
sion (BHI), in serial dilutions of logarithmic base 2, in
concentrations ranging between 100 and 6.25 mg/mL. As
a positive control, chlorhexidine digluconate was used at
concentrations between 20 and 0.015 mg/mL, and bacter-
ial growth control was performed with agar BHI without
active principle.
The assay was prepared in triplicate for each isolate, fill-
ing corresponding wells with 150 μL of culture medium
with different concentrations of β-caryophyllene, 150 μL
with chlorhexidine or 150 μL of unsupplemented culture
medium. Each well except the last row (non-inoculated as
a control of culture medium sterility) was inoculated with
3 μL of the adjusted 3 × 107 UFC/mL and the plates were
incubated for 24 h at 37 °C. After incubation, the bacterial
growth was evidenced by the addition of 50 μL resazurin
solution at 0.01 % as a colorimetric indicator of oxireduc-
tion to characterise cell viability. Interpretation of the
results was based on the conversion of resazurin in
Fig. 1 Chemical structure of β-caryophyllene (4,11,11-trimethyl-8-
methylene-bicyclo[7.2.0]undec-4-ene)
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resorufin by microbial metabolism, showing a change of
the dye colour from blue to pink when microbial growth
occurred. The MIC was based on the lowest concentration
of β-caryophyllene and chlorhexidine in which the dye
remained blue, indicating the absence of microbial
growth.
Stimulation/inhibition of bacterial adherence
The quantification of inhibition or stimulation of the
bacterial adherence was performed by a microtiter-plate
test for quantification biofilm formation according [26],
with modifications performed by [27]. Here, 24 bacterial
isolates from dog dental plaque of the following genera
were tested: Actinomyces sp. (2), Aerococcus sp. (1),
Bacillus sp. (1), Enterococcus sp. (6), Haemophilus sp.
(1), Lactobacillus sp. (1), Lactococcus sp. (2), Leuconostoc
sp. (2), Staphylococcus sp. (3) and Streptococcus sp. (5).
From the MIC of β-caryophyllene against each isolate,
six descending serial dilutions of logarithmic base 2 were
used (final concentrations). The isolates were reactivated
in BHI incubated at 37 °C for 24 h and then adjusted to
0.5 McFarland scale (1.5 × 108). For this, 230 μL of each
isolate culture was added to the wells of 96 well microti-
tre plates, and 70 μL of test solution was added to assess
the final six different concentrations of each isolate, in
triplicate. The positive control of bacterial adherence for
each isolate consisted of the addition of 230 μL of ad-
justed bacterial culture and 70 μL of sterile BHI broth,
and the negative control of bacterial adherence was pre-
pared with 300 μL of sterile BHI broth. The plates were
incubated at 37 °C for 24 h. After this period, the con-
tent was discarded from the plates and these were
washed three times with distilled water to remove non-
adhered bacteria. Then, 250 μL of methanol was added
to each well, which was allowed to stand for 15 min.
The methanol was discarded, and the plate was dried for
2 min in laminar flow, following staining with 250 μL of
1 % crystal violet per well for 10 min. The dye was removed
from the plate with tap water and then 250 μL of 33 % gla-
cial acetic acid was added. The optical density of each well
was measured by a microplate spectrophotometer. With
the aid of statistical software Prism 5 (GraphPad Software
Inc., La Jolla-CA, USA) the results were analysed by one-
way ANOVA comparing treatments to the positive control
using the Dunnett’s test.
Inhibition of dental plaque formation in dogs
Here, 18 healthy mongrel dogs, aged between 2 and
8 years old, divided randomly in males and females, were
divided into three groups: negative control group (treat
solution: tween 80, butylated hydroxytoluene, sodium
benzoate and distilled water); positive control group
(negative control solution with 0.12 % chlorhexidine
gluconate – commercial concentration of this drug) and
test group (negative control solution with 50 mg/mL of
β-caryophyllene added). The dogs were kept during the
experimental period, two by two, in masonry kennels
(1.50 m × 3.00 m).
At the beginning of the experiment, all animals were
subjected to a dental cleaning with dental ultrasound
(Profi II AS ceramic, Dabi Atlante, Ribeirão Preto,
Brazil) and curettage, for the total exclusion of dental
plaque, confirmed with a disclosing solution (0,5 % basic
fuchsin solution). The animals in each group were
treated with the respective solution twice daily for
15 days. All were fed the same dry food and water ad
libitum. At the end of the experimental period, the bac-
terial dental plaque formed on teeth vestibular surfaces,
of canines and pre molars, were observed using 0.5 %
basic fuchsin for bacterial identification. These regions
were photographed, with digital camera positioned per-
pendicularly to the imaged surface, distant 30 cm from
the animals, and the images were subjected to analysis
in graphic software ImageJ 1.44p (National Institute of
Health, Bethesda-MD, USA) to obtain the percentage of
total tooth surface area with the presence of dental
plaque. Vestibular areas of canine and all premolar teeth
of each dog were considered for this analysis. Data were
subjected to one-way ANOVA and the parametric Tukey
test was used to compare treatment means using the




The results of the MIC test for β-caryophyllene and
chlorhexidine against dental plaque bacterial isolates are
shown in Table 1. Overall, 75 % (24/32) of the tested
isolates were sensitive to β-caryophyllene at concentra-
tions up to 100 mg/mL. The results of the inhibition of
Streptococcus sp. should be highlighted, as streptococci
are described as the most important in the initial adhe-
sion of dental plaque in humans [28], and all isolates
were inhibited by β-caryophyllene. This fact suggests
that this compound could also be a potential alternative
for dental plaque inhibition in humans, after further
studies using strains isolated from human samples. The
MIC for 50 % (3/6) of isolates of Streptococcus sp. was ≤
6.25 mg/mL, for 33.3 % (2/6) was between 6.25 and
12.5 mg/mL, and for 16.7 % (1/6) was between 25 and
50 mg/mL. The isolates showed sensitivity to the tested
substance with respect to the MIC profile, as shown in
Fig. 2.
Relevant findings of antimicrobial activity by β-
caryophyllene was described by Huang et al. [15], who
found that strains of Arabidopsis thaliana flowers that did
not have the compound in their chemical composition
showed greater growth of bacteria on their stigmas
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compared with the wild type that showed β-caryophyllene
in its composition.
In vitro studies showed natural products that are
present as the major compound β-caryophyllene, with
significant antimicrobial activity, suggesting that the sub-
stance possibly participated in this activity. Da Costa et al.
[20] studied the antibacterial activity of extract of Lantana
camara, composed 31.5 % byβ-caryophyllene. The results
showed significant antimicrobial activity, especially against
Proteus vulgaris (ATCC 13315) and Escherichia coli
(ATCC 25922). Maia et al. [21] presented the antibacterial
activity of the essential oils of Vernonia remotiflora and V.
braziliana, both with more than 40 % β-caryophyllene,
with a broad spectrum of antibacterial activity, inhibiting
the growth of several tested Gram-negative and Gram-
positive bacteria, including S. aureus and Pseudomonas
aeruginosa.
Ghosh et al. [29] evaluated the activity of essential oils of
Alpinia nigra (47.7 to 49 % of β-caryophyllene) against
Gram-positive and Gram-negative bacteria. The lowest MIC
was found against Yersinia enterocolitica (1.56 μL/mL). In
the present study, Staphylococcus isolates had relatively high
MICs (one was 25 mg/mL and five were resistant up to
100 mg/mL) compared to the isolate of S. aureus in the
study of Ghosh et al. [29], which showed MICs ranging be-
tween 3.12 and 6.25 μL/mL depending on the essential oil
of A. nigra analysed. This difference in susceptibility of
bacteria of the same genus may have occurred by synergistic
action of β-caryophyllene with other substances present in
the tested oil [30], or due to the intrinsic resistance of wild
isolates of the present study to this phytotherapic was higher
when compared to that strain tested by Ghosh et al. [29].
Souza et al. [30] investigated the antibacterial activity
of β-caryophyllene against cariogenic bacteria in
humans, Streptococcus mutans, S. mitis, S. sobrinus, S.
sanguinis, and Lactobacillus casei, and showed MICs of
200, 150, 180, 200 and 150 μg/mL, respectively. These
concentrations were lower than those found in the
present study, indicating a higher susceptibility of bac-
teria in human dental plaque than those isolated from
dogs, making it an even more promising compound for
use in dental therapy in humans.
Corroborating this promising employment in human
dental therapy, Mussi [31] conducted tests of MIC with
one oil from Copaifera officinalis (with 50.78 % β-
caryophyllene) against bacteria that cause severe peri-
odontal disease in humans: Fusobacterium nucleatum
and Porphyromonas gingivalis. The solution of copaiba
was active against F. nucleatum from the concentration
Fig. 2 Distribution of sensitivity of 32 dental plaque bacterial isolates
obtained from dogs classified based on minimum inhibitory
concentrations of β-caryophyllene
Table 1 Minimum inhibitory concentrations of β-caryophyllene
and chlorhexidine against 32 bacterial isolates obtained from
dog dental plaque
Code Bacterial genus β-caryophyllene Chlorhexidine
HQ717206 Actinomyces sp. 25 (mg/mL) ≤0.015 mg/mL
HQ717208 Actinomyces sp. 12.5 (mg/mL) ≤0.015 mg/mL
HQ717237 Aerococcus sp. 25 (mg/mL) ≤0.015 mg/mL
HQ717211 Bacillus sp. 50 (mg/mL) ≤0.015 mg/mL
HQ717289 Bacillus sp. >100 (mg/mL) ≤0.015 mg/mL
HQ717176 Enterococcus sp. 50 (mg/mL) ≤0.015 mg/mL
HQ717205 Enterococcus sp. 50 (mg/mL) ≤0.015 mg/mL
HQ717227 Enterococcus sp. 50 (mg/mL) ≤0.015 mg/mL
HQ717268 Enterococcus sp. 12,5 (mg/mL) ≤0.015 mg/mL
HQ717302 Enterococcus sp. 12.5 (mg/mL) ≤0.015 mg/mL
HQ717350 Enterococcus sp. 25 (mg/mL) ≤0.015 mg/mL
HQ717319 Haemophilus sp. 100 (mg/mL) ≤0.015 mg/mL
HQ717266 Lactobacillus sp. 12.5 (mg/mL) ≤0.015 mg/mL
HQ717270 Lactobacillus sp. 50 (mg/mL) ≤0.015 mg/mL
HQ717278 Lactobacillus sp. 50 (mg/mL) ≤0.015 mg/mL
HQ717330 Lactococcus sp. 6.25 (mg/mL) ≤0.015 mg/mL
HQ717335 Lactococcus sp. 6.25 (mg/mL) ≤0.015 mg/mL
HQ717296 Leuconostoc sp. 50 (mg/mL) ≤0.015 mg/mL
HQ717308 Leuconostoc sp. >100 (mg/mL) ≤0.015 mg/mL
HQ717331 Leuconostoc sp. >100 (mg/mL) ≤0.015 mg/mL
HQ717182 Staphylococcus sp. 25 (mg/mL) ≤0.015 mg/mL
HQ717223 Staphylococcus sp. >100 (mg/mL) ≤0.015 mg/mL
HQ717224 Staphylococcus sp. >100 (mg/mL) ≤0.015 mg/mL
HQ717232 Staphylococcus sp. >100 (mg/mL) ≤0.015 mg/mL
HQ717306 Staphylococcussp. >100 (mg/mL) ≤0.015 mg/mL
HQ717309 Staphylococcus sp. >100 (mg/mL) ≤0.015 mg/mL
HQ717228 Streptococcus sp. 50 (mg/mL) ≤0.015 mg/mL
HQ717229 Streptococcus sp. 6.25 (mg/mL) ≤0.015 mg/mL
HQ717242 Streptococcus sp. 6.25 (mg/mL) ≤0.015 mg/mL
HQ717243 Streptococcus sp. 6.25 (mg/mL) ≤0.015 mg/mL
HQ717249 Streptococcus sp. 12.5 (mg/mL) ≤0.015 mg/mL
HQ717305 Streptococcus sp. 12.5 (mg/mL) ≤0.015 mg/mL
Codes presented are the respective numbers of deposit of the 16S rRNA
sequences of each isolate in GenBank
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100 μL/mL, while the MIC against P. gingivalis was
2 μL/mL. However, for P. gingivalis the nature of the
antimicrobial activity was bacteriostatic at all concentra-
tions tested, while for F. nucleatum the MIC was also
the minimum bactericidal concentration (MBC).
Stimulation/inhibition of bacterial adherence
Table 2 lists the isolates that showed some inhibition or
stimulation in its adherence capability by some sub-
inhibitory concentration of β-caryophyllene, with statis-
tical significance (P < 0.05) when compared with the
control. Within the 24 isolates tested, eight (33.33 %)
showed an altered ability to form biofilms enough to be
detected by statistical analysis. An isolate of Lactococcus
sp. suffered inhibition of its adherence by concentrations
of 1.56 mg/mL % and 3.12 mg/mL (P < 0.05), while con-
cerning the challenge with 0.19 mg/mL of β-
caryophyllene, the activity was the stimulus to the adher-
ence of the same isolate (P < 0.05). One Streptococcus sp.
and one Bacillus sp. presented similar results, being
inhibited to adhere by some concentrations and stimu-
lated by other one (Table 2).
It can be seen in Table 2 that the eight isolates that
showed statistical differences in the adherence to microtitre
plate orifices were from six different genera, Streptococcus
sp. (1/5), Haemophilus sp. (1/1), Aerococcus sp. (1/1), Lacto-
coccus sp. (1/2), Bacillus sp. (1/1) and Enterococcus sp. (3/
6). As more than one isolate of each genus were tested for
Streptococcus, Enterococcus and Lactococcus, it can be
stated, at least to these genera, that the susceptibility to
Table 2 Stimulation/Inhibition of bacterial adherence in microtiter plates by subinhibitory concentrations of β-caryophyllene
Code Bacterial genus Subinhibitory concentration (mg/mL) Action on bacterial adherence Control OD mean (SE) Treated OD mean (SE)
HQ717249 Streptococcus sp. 6.25 Inhibition 0.306 (0.018) 0.093 (0.011)
3.12 Inhibition 0.306 (0.018) 0.106 (0.009)
1.56 Inhibition 0.306 (0.018) 0.117 (0.013)
0.78 Stimulus 0.306 (0.018) 0.578 (0.021)
HQ717319 Haemophilus sp. 50.00 Inhibition 0.125 (0.001) 0.076 (0.001)
25.00 Inhibition 0.125 (0.001) 0.071 (0.001)
12.50 Inhibition 0.125 (0.001) 0.087 (0.004)
6.25 Inhibition 0.125 (0.001) 0.089 (0.003)
HQ717330 Lactococcus sp. 3.12 Inhibition 1.072 (0.050) 0.203 (0.065)
1.56 Inhibition 1.072 (0.050) 0.458 (0.080)
0.19 Stimulus 1.072 (0.050) 1.590 (0.157)
HQ717350 Enterococcus sp. 12.50 Inhibition 0.209 (0.005) 0.076 (0.001)
HQ717176 Enterococcus sp. 25.00 Inhibition 0.114 (0.003) 0.075 (0.001)
12.50 Inhibition 0.114 (0.003) 0.073 (0.005)
6.25 Inhibition 0.114 (0.003) 0.065 (0.001)
1.56 Inhibition 0.114 (0.003) 0.073 (0.003)
HQ717227 Enterococcus sp. 25.00 Inhibition 0.676 (0.061) 0.094 (0.017)
12.50 Inhibition 0.676 (0.061) 0.075 (0.007)
6.25 Inhibition 0.676 (0.061) 0.068 (0,001)
3.12 Inhibition 0.676 (0.061) 0.083 (0.005)
1.56 Inhibition 0.676 (0.061) 0.122 (0.017)
HQ717211 Bacillus sp. 25.00 Inhibition 0.398 (0.008) 0.088 (0.013)
12.50 Inhibition 0.398 (0.008) 0.077 (0.009)
6.25 Inhibition 0.398 (0.008) 0.112 (0.031)
3.12 Inhibition 0.398 (0.008) 0.168 (0.019)
1.56 Stimulus 0.398 (0.008) 0.517 (0.055)
HQ717237 Aerococcus sp. 12.50 Inhibition 0.119 (0.005) 0.082 (0.002)
1.56 Inhibition 0.119 (0.005) 0.071 (0.001)
Codes presented are the respective numbers of deposit of the 16S rRNA sequences of each isolate in GenBank. Means (±SE) of optical density are related to measurement
under 550 nm absorbance (OD550). All of the presented results showed a significant difference between the test treatment and the control of isolates natural adherence
without any treatment (P< 0.05)
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changes in adherence capability is characterised in strain
level. This fact was presented before [6], with different E.
coli strains presenting different interference levels in biofilm
formation when challenged by enrofloxacin.
Pieri et al. [3] studied the effects of Copaifera officina-
lis oil, which is described in the work of Mussi [31] as
containing more than 50 % β-caryophyllene, on the ad-
hesion of the bacteria Streptococcus mutans, the main
involved in the initial formation of dental plaque in
humans. Analysis of the inhibition of adherence assays
showed superiority of the test group compared with the
negative control and positive control with chlorhexidine.
In the present study, an isolate of the same genus had its
adhesiveness inhibited by sub-inhibitory concentrations
of β-caryophyllene between 1.56 and 6.25 mg/mL and
stimulated to adhere at 0.78 mg/mL. However, other iso-
lates of Streptococcus sp. were also tested, but presented
no significant change in their ability to adhere, which
supports the individuality of each strain with respect to
variation in adherence capability by the tested compound.
Mussi [31] conducted tests to evaluate the co-aggregation
and self-aggregation (processes related to microbial adher-
ence in dental plaque of the advanced periodontal disease)
by the periodontal pathogens Fusobacterium nucleatum
and Porphyromonas gingivalis challenged with sub-
inhibitory concentrations of Copaifera officinalis oil,
composed of 50.78 % of β-caryophyllene. When F. nuclea-
tum was treated, a reduction in the self-aggregation process
was observed when compared to untreated cells. P.
gingivalis was not able to self-aggregate under the tested
conditions. The solution of C. officinalis tested also inhib-
ited co-aggregation between these two bacterial species,
which is an important event in the progression of periodon-
tal disease in humans, again demonstrating the great em-
ployment potential of β-caryophyllene in human dentistry.
It’s significant to highlight that in the present work
we used aerobes as target strains. This kind of bacteria
are not involved in the etiology of periodontal disease,
but are critical to early stages in development of dental
biofilm, creating from its installation, a favorable environ-
ment for the development of anaerobes, which actively
participate in the development of the disease [32]. Thus
the results of this study point to a relevant activity of β-
caryophyllene on aerobes, presenting relevant potential in
use to combat dental plaque formation in its early stages.
The use in combating plaque formation could promote a
prevention of the disease through a reduction of the envir-
onmental conditions that promote the development of
periodontal pathogens in the biofilm. However, further
studies should be conducted evaluating the direct anti-
microbial effect on the anaerobic periodontal pathogens,
which may point, beyond the preventive potential, the
possibility of use β-caryophyllene in the treatment of
disease.
Inhibition of dental plaque formation in dogs
The results obtained in the in vivo assay are shown in
Fig. 3. The results indicated the coverage area of teeth
with plaque (mean ± SE) to be 23.3 ± 2.6 % for β-
caryophyllene test solution, 37.5 ± 3.7 % for the positive
control solution and 65.56 ± 2.5 % coverage for the nega-
tive control solution. The test and positive control groups
were statistically lower on average than the negative con-
trol (P < 0.001) dental plaque presence and were different
(P < 0.05) with regard to inhibiting dental plaque forma-
tion, with better results for β-caryophyllene. These results
indicate that β-caryophyllene is a potential natural alterna-
tive to the use of chlorhexidine in reducing dental plaque
in dogs, resulting in a patent application of pharmaceut-
ical formulations containing β-caryophyllene for use in
the treatment and prophylaxis of canine periodontal
disease [33].
A similar assay was performed by Pieri et al. [3] using
one Copaifera officinalis oil with good results in the in-
hibition of dental plaque formation when compared to
negative control. In their work, chlorhexidine reduced
the formation of dental plaque to a final coverage of
28.5 % of the analysed area of teeth, while in the present
work, the group treated with the same substance pre-
sented 37.5 % plaque coverage. This difference could be
happen due to different susceptibility to chlorhexidine of
the dogs’ dental microbiota in the different works, or the
different treatment periods, which was 8 days in the pre-
vious work and 15 days in the current study. However, it
is interesting to highlight that the level of final plaque
coverage of groups treated with C. officinalis [3] and β-
caryophyllene (present work) were very close. As this oil
is frequently associated with high concentrations of β-
Fig. 3 Dental plaque coverage on teeth surfaces in eighteen dogs (six
per group), after 15 days of treatment with different solutions. Results are
expressed by percentage of total area of vestibular surface of canines and
premolars teeth that was covered by plaque. Results were submitted to
ANOVA and means were compared by tukey test. Different letters
(a, b and c) indicate statistical significant difference (P <0.05).
central bars: mean; marginal bars: standard error
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caryophyllene, the activity of C. officinalis oil used in
that work against dogs’ dental plaque [3] could be due
to the presence of this compound.
Conclusions
With the data obtained it can be concluded that β-
caryophyllene has antimicrobial activity against dental
plaque bacteria of dogs, and this activity is reflected in the
reduction of this on the teeth surfaces of dogs. Therefore,
after other clinical trials with a larger number of dogs and
different breeds, β-caryophyllene could be indicated as an
alternative to the use of chlorhexidine in the treatment
and prophylaxis of periodontal disease in these animals.
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